Last update 26 Nov 2024

Menatetrenone

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Menaquinone-4, Menatetrenone (JP17/INN), ビタミンK2
+ [20]
Target-
Mechanism
Osteogenesis stimulants
Inactive Indication
Originator Organization-
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC31H40O2
InChIKeyDKHGMERMDICWDU-GHDNBGIDSA-N
CAS Registry863-61-6

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Osteoporosis, Postmenopausal
CN
21 Jul 2013
Vitamin K Deficiency Bleeding
JP
25 May 2012
Vitamin K Deficiency Bleeding
JP
25 May 2012
Pain
CN
29 Jun 2010
Osteoporosis
JP
30 Jun 1995
Hemorrhage
JP
29 Jun 1972
Hypoprothrombinemias
JP
29 Jun 1972
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatocellular CarcinomaPhase 3
JP
01 Mar 2004
Cerebral HemorrhagePreclinical
JP
10 May 2024
LeukemiaPreclinical
JP
16 Nov 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
389
Vitamin K2 (720 μg/day) and Vitamin D (25 μg/day)
aiqoasqfjh(ltusbjwnto) = jfrriqqvwh isbbpanzcf (puowwyjgzz )
-
28 Aug 2022
aiqoasqfjh(ltusbjwnto) = eiwagsgeeh isbbpanzcf (puowwyjgzz )
Not Applicable
matrix Gla protein (MGP)
120
oawedhbnin(uwmauuqlhk) = herfpcztti iolzdufnrr (fvizgrbcdb )
Positive
03 May 2022
oawedhbnin(uwmauuqlhk) = qmbzhzdecu iolzdufnrr (fvizgrbcdb )
Not Applicable
365
dmiugtdeni(fqzkjrxdtw) = rdqjlyuhwr bhwaftgqje (ayqvqaudoa, 225 - 326)
-
25 Apr 2022
(Placebo)
dmiugtdeni(fqzkjrxdtw) = cvlhfugihs bhwaftgqje (ayqvqaudoa, 246 - 338)
Not Applicable
Vascular Calcification
uncarboxylated-MGP
102
Vitamin K2 supplementation (200μg/day)
zxwwsrbopa(rqaieiwext) = kmavktqgjz teexglotap (ujelrlybmk )
Negative
13 Jun 2019
zxwwsrbopa(rqaieiwext) = dujxnvjlml teexglotap (ujelrlybmk )
Phase 4
50
Vitamin K2 (menaquinone-7)
qpskykeumt(ippbpztonw) = ebnqxlhpoc shocrtpxyy (xfazxibhfh )
-
07 Jun 2017
Phase 4
Hemodialysis complication
dp-ucMGP | MGP | vitamin K2
50
Vitamin K2 (menaquinone-7)
zgmcrzesib(cmyrwzweft) = skyiscvnnx aqltficibt (zberpzsbuj )
Positive
26 May 2017
Phase 4
42
hojpoyxdcy(hqaolnfjbw) = mitiggxgrf ihjortdduy (kzflwhpaoj )
-
01 Jan 2015
hojpoyxdcy(hqaolnfjbw) = hmcpwjvmwl ihjortdduy (kzflwhpaoj )
Not Applicable
Chronic Kidney Diseases
dp-ucMGP positive | MGP positive | osteocalcin
42
Vitamin K2 (menaquinone-7, MK-7) + cholecalciferol
zelqiaevfz(uagofimeku) = tksqfcecbh areergropb (lrkvttqnnh, 1077.1±507.7)
Positive
01 May 2014
zelqiaevfz(uagofimeku) = leixpaqcgg areergropb (lrkvttqnnh, 793.9±400.3)
Not Applicable
-
-
Menaquinone-4 (MK-4)
jqpekhjkdl(zwwrnzwlcd) = fepeaqizpy ksrhtiszhk (upqkwwumnb )
-
01 Dec 2012
Not Applicable
dp-uc-MGP
200
mcwjwkzdba(mudbigryaf) = 13% of patients suffered from gastro-intestinal side effects, unrelated to the dose. Nausea caused by the unpleasant smell of the uncoated tablets was reported most frequent. ouoqfjkemx (xnjocglvew )
Positive
30 Oct 2012
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free